Personalis and Tempus AI just moved. Here's exactly what to do next.
Who to reach, what to say, and why now — on Personalis and Tempus AI, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).
Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.
Personalis and Tempus Expand Collaboration to Bring Ultra-Sensitive MRD Testing to Market
Contract Type
partnership
FremontBiotechnologyHealth CareDescription
Personalis, Inc. and Tempus AI, Inc. have announced an expanded commercial relationship to bring ultra-sensitive MRD testing to the market. This expansion includes Tempus exercising existing warrants to purchase 9.2 million shares of common stock and an additional purchase of 3.5 million shares at a price per share of $5.07, resulting in a total investment of approximately $36 million in Personalis